Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a <i>post-hoc</i> analysis from the ADDENDA-BHS 2 trial

Authors

Institutions

Publication Details

Journal
Current Medical Research and Opinion
Published
2024-12-20
DOI
https://doi.org/10.1080/03007995.2024.2442040
Citations
1
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a post-hoc analysis from the ADDENDA-BHS 2 trial

Wilson Nadruz, Íkaro Breder, Sheila T. Kimura-Medorima, Pamela Cavalcante et al.
1 citations
Current Medical Research and Opinion
Blood Pressure and Hypertension Studies
0.40
article

Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a post-hoc analysis from the ADDENDA-BHS 2 trial

Wilson Nadruz, Íkaro Breder, Sheila T. Kimura-Medorima, Pamela Cavalcante, Andrei C. Spósito, Joaquim Barreto
article en
1 citations

Abstract

No abstract available for this paper.
Current Medical Research and OpinionVol. 41(1)
Universidade Estadual de Campinas (UNICAMP) (BR), Hospital de Clínicas da Unicamp (BR), Institute for Atherosclerosis Research (RU)
Good health and well-being
Openalex Percentile: Top 29%
Blood Pressure and Hypertension Studies
0.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.